Dr. Michael K. McCray, MD

Dr. McCray practices at Tourney Plaza Surgical Center in Valencia, California.

Dr. McCray's NPI, 1235282856, was assigned on January 18, 2007. Dr. McCray graduated from Keck School of Medicine of USC in 1978. Dr. McCray holds California license G46675.

Dr. McCray's primary practice is Tourney Plaza Surgical Center, at 27420 Tourney Road, Suite 160, Valencia, CA 91355. The practice phone is (661) 259-3937.

Dr. McCray's primary practice is Tourney Plaza Surgical Center in Valencia, California. The medical group on file is McCray Dermatology. Dmand AI also links Dr. McCray to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. McCray practices, 2 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. McCray's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. McCray is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. McCray's licenses on file in 4 states: California, Utah, Tennessee and Illinois.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, contact dermatitis, itchy rashes, joint cyst, scalp rash and shingles among the conditions Dr. McCray treats.

CMS data shows 4,744 Medicare services from Dr. McCray across 12 procedure codes in 2024, for 911 Medicare patients. Medicare paid $200,951 for them. Every service was in an office.

CMS counts 911 Medicare patients who saw Dr. McCray in 2024. The largest group is 65 to 74, with 485 patients. 75% of them have high cholesterol, and 73% have high blood pressure. Their average risk score is 0.94, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. McCray's median patient age at 64, with 52% women.

In 2024, Dr. McCray wrote 415 Medicare Part D claims for 217 patients. 99% of them were for generic drugs. CMS names the drug for 331 of them, across 11 drugs with 11 or more claims each, at $8,380 in total drug cost. In 2023, CMS named 257 claims across 9 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Dr. McCray for performance year 2024, reported as part of a group. Dr. McCray accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 455 procedures of skin biopsy by Dr. McCray, more than 95% of the clinicians it reports for that procedure.

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 32 general payments to Dr. McCray from 18 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 100% of the total. UCB, Inc. paid the most, $126.

Dmand AI lists 3 awards for Dr. McCray, most recently ASDS Fellow in 2012.

Dr. McCray graduated from Keck School of Medicine of USC in 1978. Dr. McCray is a member of AAD and ASDS.

Dr. McCray is in network with 16 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.